John Bartlett, BSc, PhD, FRCPath, Ontario Institute for Cancer Research, Ontario, Canada, discusses how the increased availability of genomic tools has impacted treatment decision making and highlights challenges and goals for molecular profiling approaches in the future. This interview took place at the virtual European Society for Medical Oncology (ESMO) Breast Cancer Congress 2021.